We would like to announce
Research Strategy 2012-2020
Since our foundation in 1996 we have awarded over £15 million to
innovative research aimed at extending and improving the lives of
men who are diagnosed with prostate cancer. In 2012 we move
our research funding to a new level; thanks to the income raised by
the Movember Foundation we will begin committing over £7 million to
new research each year for at least the next three years. Our
new research strategy outlines how we think we can best invest this
vastly increased sum to achieve real differences for men affected
by prostate cancer by the year 2020.
Described in our new Research
Strategy 2012-20 are three priority research areas and the
funding mechanisms we will use to help accelerate research in these
areas. From 2012-2020 all our research funding will be
- identifying men at highest risk of developing aggressive
- better tests to distinguish indolent from aggressive tumours,
- new targeted treatments for advanced prostate cancer.
Our new funding streams emphasise innovation, collaboration,
training and career development.